Stockscreener 앱 받기
13.76
0.00%
0.00
전일 마감가:
$13.76
열려 있는:
$13.76
하루 거래량:
4.05M
Relative Volume:
1.57
시가총액:
$3.61B
수익:
$6.16B
순이익/손실:
$246.00M
주가수익비율:
14.66
EPS:
0.9387
순현금흐름:
$708.00M
1주 성능:
+0.07%
1개월 성능:
+1.55%
6개월 성능:
+88.75%
1년 성능:
+46.07%
1일 변동 폭
$13.75
$13.77
1주일 범위
$13.74
$13.77
52주 변동 폭
$5.69
$13.77
오가논 & Co Stock (OGN) Company Profile
명칭
Organon Co
전화
551-430-6000
주소
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, MRK, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
13.76 | 3.61B | 6.16B | 246.00M | 708.00M | 0.9387 |
LLY
Lilly Eli Co
|
1,156.73 | 1.11T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
265.85 | 644.33B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
256.42 | 462.68B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
147.76 | 367.58B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
152.06 | 296.97B | 54.66B | 13.58B | 16.05B | 7.0171 |
오가논 & Co Stock (OGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-10-27 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-09-06 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-11-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-09-21 | 개시 | Barclays | Overweight |
| 2023-03-16 | 개시 | Raymond James | Outperform |
| 2022-10-14 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-09-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 개시 | Piper Sandler | Neutral |
| 2021-09-01 | 개시 | BofA Securities | Buy |
| 2021-07-22 | 개시 | Citigroup | Buy |
| 2021-06-15 | 개시 | JP Morgan | Neutral |
| 2021-06-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 개시 | Evercore ISI | Outperform |
모두보기
오가논 & Co 주식(OGN)의 최신 뉴스
Organon (OGN) Move: Ends Up by 0.07% at $13.74 on the Day; Technical Setup: the $13.05 to $14.43 Range Remains in FocusBox Spread - Vinanet
Sun Pharma completes $11.75bn financing syndication for Organon acquisition - Generics and Biosimilars Initiative
Organon (OGN) Trading: Ends Up by 0.37% at $13.73 at the Close; Next Session: the Supplied Trading Band Runs From $13.04 to $14.42 under the Current SnapshotOvernight Profile - Vinanet
Organon & Co stock hits 52-week high at 13.73 USD - Investing.com
Organon & Co. (NYSE:OGN) Reaches New 12-Month HighStill a Buy? - MarketBeat
OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits
Orographic Financial Advisors, LLC's Organon & Co(OGN) Holding History - GuruFocus
how InvestingPro’s Fair Value spotted Organon’s 69% gain potential By Investing.com - Investing.com South Africa
Organon (OGN): Pentwater Capital discloses 18.1M-share, 6.9% ownership stake - Stock Titan
Kevin Hern sells stocks in Organon & Co. and Versant Media Group - Investing.com Nigeria
Kevin Hern sells stocks in Organon & Co. and Versant Media Group By Investing.com - Investing.com Australia
This House of Representative Just Sold Up To $30K In Organon Stock - Benzinga
Organon & Co To Go Ex-Dividend On August 14th, 2026 With 0.02 USD Dividend Per Share - 富途牛牛
Organon & Co. (NYSE:OGN) Reaches New 1-Year HighShould You Buy? - MarketBeat
Sei Investments Co. Has $1.14 Million Holdings in Organon & Co. $OGN - MarketBeat
Quantinno Capital Management LP Sells 98,466 Shares of Organon & Co. $OGN - MarketBeat
Organon & Co. R&D Chief Juan Camilo Arjona Ferreira Completes Final RSU Vesting and Tax Withholding - Kalkine Media
Organon & Co. (OGN) CMO exercises 11,519 RSUs and withholds 4,134 shares for costs - Stock Titan
Organon & Co. $OGN Shares Purchased by California State Teachers Retirement System - MarketBeat
Rep. Kevin Hern Sells Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Trading the Move, Not the Narrative: (OGN) Edition - Stock Traders Daily
Organon opens enrollment for Miudella IUD safety program By Investing.com - Investing.com Australia
Organon opens enrollment for Miudella IUD safety program - Investing.com
Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability - Business Wire
Organon earnings in focus as Sun Pharma deal looms By Investing.com - Investing.com UK
Organon earnings in focus as Sun Pharma deal looms - Investing.com
Organon & Co stock hits 52-week high at 13.61 USD - Investing.com Australia
Organon & Co. (NYSE:OGN) Reaches New 52-Week HighShould You Buy? - MarketBeat
Organon & Co. $OGN Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Organon & Co. (OGN) Stock Forecasts - Yahoo Finance
OGN (NYSE: OGN) details 14,761-share Rule 144 common stock sale plan - Stock Titan
Organon & Co. (OGN) Stock Analysis: Valuation Insights and Investor Outlook Amidst Market Challenges - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Weekly Recap: Moody's upgrade prospect after Sun Pharmaceutical and Q2 EPS $0.85 - TradingView
Organon Co earnings missed by $0.50, revenue fell short of estimates - Investing.com
Organon & Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Organon declares $0.02 quarterly dividend per share By Investing.com - Investing.com Nigeria
Organon: Q2 Earnings Snapshot - WKYC
Press Release: Organon Announces Quarterly Dividend - Moomoo
Organon & Co. (NYSE:OGN) to Issue $0.02 Quarterly Dividend - MarketBeat
First Trust Advisors LP Has $19.33 Million Position in Organon & Co. $OGN - MarketBeat
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
OGN|Organon & Co|Price:13.535|Chg%:+0.015 - TradingKey
Organon & Co. (OGN) to Announce Quarterly Earnings on Tuesday - MarketBeat
India healthcare M&A hits record value as pharma takes centre stage - DealStreetAsia
OGN Looks 6.8% Undervalued on GF Value™ - GuruFocus
오가논 & Co (OGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.79%
0.61%
자본화:
|
볼륨(24시간):